- Home
- EVTV vs CVKD Comparison
EVTV vs CVKD Comparison
Compare EVTV & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- CVKD
- Stock Information
- Founded
- EVTV 2012
- CVKD 2022
- Country
- EVTV United States
- CVKD United States
- Employees
- EVTV N/A
- CVKD N/A
- Industry
- EVTV Auto Manufacturing
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- EVTV Consumer Discretionary
- CVKD Health Care
- Exchange
- EVTV Nasdaq
- CVKD Nasdaq
- Market Cap
- EVTV 24.6M
- CVKD 20.8M
- IPO Year
- EVTV 2017
- CVKD 2023
- Fundamental
- Price
- EVTV $1.38
- CVKD $12.96
- Analyst Decision
- EVTV
- CVKD Strong Buy
- Analyst Count
- EVTV 0
- CVKD 2
- Target Price
- EVTV N/A
- CVKD $46.00
- AVG Volume (30 Days)
- EVTV 61.3K
- CVKD 64.9K
- Earning Date
- EVTV 11-14-2024
- CVKD 11-07-2024
- Dividend Yield
- EVTV N/A
- CVKD N/A
- EPS Growth
- EVTV N/A
- CVKD N/A
- EPS
- EVTV N/A
- CVKD N/A
- Revenue
- EVTV $1,730,010.00
- CVKD N/A
- Revenue This Year
- EVTV N/A
- CVKD N/A
- Revenue Next Year
- EVTV N/A
- CVKD N/A
- P/E Ratio
- EVTV N/A
- CVKD N/A
- Revenue Growth
- EVTV N/A
- CVKD N/A
- 52 Week Low
- EVTV $1.06
- CVKD $5.40
- 52 Week High
- EVTV $3.20
- CVKD $32.55
- Technical
- Relative Strength Index (RSI)
- EVTV 39.46
- CVKD 47.69
- Support Level
- EVTV $1.33
- CVKD $10.65
- Resistance Level
- EVTV $1.43
- CVKD $12.25
- Average True Range (ATR)
- EVTV 0.11
- CVKD 1.50
- MACD
- EVTV 0.00
- CVKD -0.12
- Stochastic Oscillator
- EVTV 23.81
- CVKD 45.85
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.